Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hi-Tis is a French biotechnology company specializing in the development of advanced 3D human tissue models for preclinical drug discovery and toxicology. The company's proprietary platform enables high-throughput, in situ histological analysis of complex cell cultures, providing more physiologically relevant data than traditional 2D models. By bridging the gap between in vitro assays and in vivo studies, Hi-Tis helps pharmaceutical and cosmetic companies optimize their drug development pipelines and reduce reliance on animal testing. Their services include custom tissue engineering and automated imaging solutions designed to preserve the spatial architecture of biological samples.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hi-Tis.